Surface engineered Amphora subtropica frustules using chitosan as a drug delivery platform for anticancer therapy

Drug delivery using synthetic mesoporous nanomaterials, including porous silicon, has been extensively used to ameliorate the constraints currently experienced with conventional chemotherapy. Owing to the amazing potential, the silica based nanomaterials have been used widely. Nevertheless, syntheti...

Full description

Bibliographic Details
Main Authors: Sasirekha, R, Sheena, T, Sathiya Deepika, M, Santhanam, P, Townley, H, Jeganathan, K, Dinesh Kumar, S, Premkumar, K
Format: Journal article
Published: Elsevier 2018
_version_ 1797080420295114752
author Sasirekha, R
Sheena, T
Sathiya Deepika, M
Santhanam, P
Townley, H
Jeganathan, K
Dinesh Kumar, S
Premkumar, K
author_facet Sasirekha, R
Sheena, T
Sathiya Deepika, M
Santhanam, P
Townley, H
Jeganathan, K
Dinesh Kumar, S
Premkumar, K
author_sort Sasirekha, R
collection OXFORD
description Drug delivery using synthetic mesoporous nanomaterials, including porous silicon, has been extensively used to ameliorate the constraints currently experienced with conventional chemotherapy. Owing to the amazing potential, the silica based nanomaterials have been used widely. Nevertheless, synthetic nanomaterial involves high cost, lack of scalability, and the use of toxic substances limits its utilization. These issues can be overcome by the use of nature generated nanoscale materials, such as diatoms would serve as a boon for pharmaceutical industries. In this study we investigate the use of a mesoporous, biodegradable nanomaterial obtained from the natural silica found in the diatom species Amphora subtropica (AMPS) for drug delivery applications. AMPS cultures cleaned and chemically treated to obtain Amphora frustules (exoskeleton) (AF), followed by surface functionalization with chitosan (Chi). Results of our experiments demonstrate high drug loading, strong luminescence, biodegradable and biocompatible nature of the doxorubicin tethered diatom. Further, toxicity studies employing immortalized lung cancer cell line (A549) indicates sustained drug delivery and less toxic compared to the free doxorubicin (DOX), suggesting AF could be an excellent substitute for synthetic nanomaterials used in drug delivery applications.
first_indexed 2024-03-07T00:59:46Z
format Journal article
id oxford-uuid:8950ef16-b294-4c8a-9af0-4d8823cd4d6c
institution University of Oxford
last_indexed 2024-03-07T00:59:46Z
publishDate 2018
publisher Elsevier
record_format dspace
spelling oxford-uuid:8950ef16-b294-4c8a-9af0-4d8823cd4d6c2022-03-26T22:23:41ZSurface engineered Amphora subtropica frustules using chitosan as a drug delivery platform for anticancer therapyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8950ef16-b294-4c8a-9af0-4d8823cd4d6cSymplectic Elements at OxfordElsevier2018Sasirekha, RSheena, TSathiya Deepika, MSanthanam, PTownley, HJeganathan, KDinesh Kumar, SPremkumar, KDrug delivery using synthetic mesoporous nanomaterials, including porous silicon, has been extensively used to ameliorate the constraints currently experienced with conventional chemotherapy. Owing to the amazing potential, the silica based nanomaterials have been used widely. Nevertheless, synthetic nanomaterial involves high cost, lack of scalability, and the use of toxic substances limits its utilization. These issues can be overcome by the use of nature generated nanoscale materials, such as diatoms would serve as a boon for pharmaceutical industries. In this study we investigate the use of a mesoporous, biodegradable nanomaterial obtained from the natural silica found in the diatom species Amphora subtropica (AMPS) for drug delivery applications. AMPS cultures cleaned and chemically treated to obtain Amphora frustules (exoskeleton) (AF), followed by surface functionalization with chitosan (Chi). Results of our experiments demonstrate high drug loading, strong luminescence, biodegradable and biocompatible nature of the doxorubicin tethered diatom. Further, toxicity studies employing immortalized lung cancer cell line (A549) indicates sustained drug delivery and less toxic compared to the free doxorubicin (DOX), suggesting AF could be an excellent substitute for synthetic nanomaterials used in drug delivery applications.
spellingShingle Sasirekha, R
Sheena, T
Sathiya Deepika, M
Santhanam, P
Townley, H
Jeganathan, K
Dinesh Kumar, S
Premkumar, K
Surface engineered Amphora subtropica frustules using chitosan as a drug delivery platform for anticancer therapy
title Surface engineered Amphora subtropica frustules using chitosan as a drug delivery platform for anticancer therapy
title_full Surface engineered Amphora subtropica frustules using chitosan as a drug delivery platform for anticancer therapy
title_fullStr Surface engineered Amphora subtropica frustules using chitosan as a drug delivery platform for anticancer therapy
title_full_unstemmed Surface engineered Amphora subtropica frustules using chitosan as a drug delivery platform for anticancer therapy
title_short Surface engineered Amphora subtropica frustules using chitosan as a drug delivery platform for anticancer therapy
title_sort surface engineered amphora subtropica frustules using chitosan as a drug delivery platform for anticancer therapy
work_keys_str_mv AT sasirekhar surfaceengineeredamphorasubtropicafrustulesusingchitosanasadrugdeliveryplatformforanticancertherapy
AT sheenat surfaceengineeredamphorasubtropicafrustulesusingchitosanasadrugdeliveryplatformforanticancertherapy
AT sathiyadeepikam surfaceengineeredamphorasubtropicafrustulesusingchitosanasadrugdeliveryplatformforanticancertherapy
AT santhanamp surfaceengineeredamphorasubtropicafrustulesusingchitosanasadrugdeliveryplatformforanticancertherapy
AT townleyh surfaceengineeredamphorasubtropicafrustulesusingchitosanasadrugdeliveryplatformforanticancertherapy
AT jeganathank surfaceengineeredamphorasubtropicafrustulesusingchitosanasadrugdeliveryplatformforanticancertherapy
AT dineshkumars surfaceengineeredamphorasubtropicafrustulesusingchitosanasadrugdeliveryplatformforanticancertherapy
AT premkumark surfaceengineeredamphorasubtropicafrustulesusingchitosanasadrugdeliveryplatformforanticancertherapy